688161 威高骨科
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)1.0616.6355.7212.53112.597
总资产报酬率 ROA (%)0.8635.3684.4552.02110.521
投入资产回报率 ROIC (%)1.0286.3765.3782.40712.203

边际利润分析
销售毛利率 (%)60.47864.87865.73166.52276.577
营业利润率 (%)17.73421.23818.70310.19834.330
息税前利润/营业总收入 (%)17.68320.65317.5698.22832.454
净利润/营业总收入 (%)14.61717.98015.7148.81129.172

收益指标分析
经营活动净收益/利润总额(%)82.28097.06495.74483.05896.462
价值变动净收益/利润总额(%)11.2689.92710.00321.1333.903
营业外收支净额/利润总额(%)0.1020.200-0.2800.556-0.042

偿债能力分析
流动比率 (X)4.7594.9914.8823.9245.905
速动比率 (X)4.0734.3084.0823.2315.155
资产负债率 (%)18.52817.81619.90323.98616.783
带息债务/全部投入资本 (%)2.2501.8342.0753.5980.957
股东权益/带息债务 (%)4,294.1845,304.5044,572.5372,588.71110,105.757
股东权益/负债合计 (%)436.229459.648401.460316.487495.813
利息保障倍数 (X)-255.360-32.901-16.241-4.059-17.434

营运能力分析
应收账款周转天数 (天)92.56765.29170.050115.56675.762
存货周转天数 (天)466.742429.408520.785594.996459.860